The role of rituximab in the treatment of ANCA-associated vasculitides (AAV). Swiss Medical Weekly, [S. l.], v. 145, n. 0506, p. w14103, 2015. DOI: 10.4414/smw.2015.14103. Disponível em: https://smw.ch/index.php/smw/article/view/1980. Acesso em: 26 nov. 2025.